Innovation Zed Appoints New CEO
Dublin, Ireland 3rd April 2020
We are happy are to announce that Innovation Zed has appointed Dean Minnock as the new Chief Executive Officer following the retirement of Former CEO and Co-Founder John Hughes.
Innovation Zed develops a range of smart add-on technologies for injection pens. Recently, Innovation Zed entered into a commercial partnership with diagnostics and preventive medicine company A. Menarini Diagnostics.
Dean was one of the original employees of Innovation Zed and has extensive experience with both operational and commercial functions of the company. Dean holds a PhD degree from University College Dublin’s School of Public Health, Physiotherapy & Sports Science.
John Hughes, the current director, shareholder and co-founder of Innovation Zed, will continue to share his professional knowledge of the market and provide his invaluable support to the company as an Executive Board Director.
Media Files
About Innovation Zed
Innovation Zed designs connected health solutions that support drug adherence and condition management. As technologies continue to evolve, it opens new and exciting possibilities for connected healthcare to deliver increased freedom and control to patients. That is why Innovation Zed is actively developing and researching new methods to improve drug adherence and enable more personalised condition management. Visit www.innovationzed.com to learn more.